Aptamer extends contract with Unilever to progress Optimer for deodorant development

Lab-test results of Optimer indicate good applicability in deodorant products.

Sanford Health aims to shake off a run of failed deals by snapping up a $3 billion Wisconsin health system

Fourth time’s the charm? Sanford Health is hoping so. Less than a year after scrapping its proposed merger with a Minnesota health system — its

July 10, 2024

AstraZeneca mulls risk strategy for Ultomiris following FDA response letter – Pharmaceutical Technology

The therapy is approved for NMOSD in multiple regions, including the European Union (EU) and Japan. Image Credit: Roland Magnusson / Shutterstock. The US Food

September 6, 2023

Compugen, Nxera disclose milestone payments; Insmed aims for $650M offering

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.